Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Harte-Hanks Q4 2023 Adj EPS $0.51 Beats $0.12 Estimate, Sales $49.491M Beat $47.000M Estimate

Author: Benzinga Newsdesk | March 14, 2024 04:25pm
Harte-Hanks (NASDAQ:HHS) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.12 by 325 percent. The company reported quarterly sales of $49.491 million which beat the analyst consensus estimate of $47.000 million by 5.30 percent. This is a 9.65 percent decrease over sales of $54.778 million the same period last year.

Posted In: HHS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist